MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
    • Skincare
  • News & Media
  • Contact Us
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Cancer Immunotherapy
    • Retinal Degeneration
    • Skincare
  • News & Media
  • Contact Us
  •  
  • June 2016

AiVita Biomedical Receives FDA Approval for Phase II Ovarian Cancer Treatment

AIVITA Biomedical is an Irvine, CA based company focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development.

Recent News

  • Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical’s Phase 2 Clinical Trial
  • AIVITA Biomedical Receives Import Approval to Distribute its Professional ROOT of SKIN™ MD Skincare Line in Japan
  • AIVITA Biomedical to Exhibit Skincare Products at ‘The Aesthetic Show’ and ‘AAD Summer Meeting’ in July
  • AIVITA Biomedical Announces New Clinical Data in Ongoing Phase 2 Brain Cancer Trial
  • ROOT OF SKIN™ Skincare Line Sells out in Eighth Consecutive Appearance on QVC Japan

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2017 | AIVITA Biomedical